// App-Quantinova.ai

TCT-419 : Usefulness of a scoring system for predicting adverse cardiovascular events in patients undergoing everolimus-eluting bioresorbable scaffolds implantation: the PSP score

Researchers

Presenter

  • Luis Ortega-Paz

Principal Investigators

  • Davide Capodanno

  • Tommaso Gori

  • Holger Nef

  • Azeem Latib

  • Giuseppe Caramanno

  • Carlo Di Mario

  • Christoph Naber

  • Maciej Lesiak

  • Piera Capranzano

  • Jens Wiebe

Medical Centers

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Interventional Cardiology Institute San Raffaele Hospital, Milan, Italy

  • Contilia Heart and Vascular Center, Essen, Germany

  • San Raffaele Scientific Institute, Milan, Italy

  • Medizinische Klinik und Poliklinik, Universitatsmedizin Mainz, University Medical Center, Mainz, Germany

  • AOU Careggi, Florence, Italy

  • Poznan University of Medical Sciences, Poznan, Poland

  • University of Giessen, Giessen, Germany

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • University Hospital, Poznan, Poland

  • Munich University Clinic, Munich, Germany

  • Klinik fur Kardiologie und Angiologie, Elisabeth-Krankenhaus, Essen, Germany

  • Ferrarotto Hospital, Cardiology Division, University of Catania, Catania, Italy

  • hospital, Agrigento, Italy

  • San Giovanni di Dio Hospital, Agrigento, Italy

  • Ferrarotto Hospital, Cardiology Division, University of Catania, Catania, Italy

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • Italy

  • Poland

  • Spain

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • Regenerating islet-derived 1 alpha

Drug/Treatment

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim